Time to mandate data release and independent audits for all clinical trials

Ian E Haines and George L Gabor Miklos
Med J Aust 2011; 195 (10): . || doi: 10.5694/mja11.10599
Published online: 21 November 2011

As a condition of publication of phase III clinical trials, medical journals should insist on the release of all raw data and a written independent clinical audit

Editorials and commentaries in some high-profile journals herald an upcoming revolution in personalised oncology.1 However, any new treatment can only be considered an advance if it:

  • Ian E Haines1
  • George L Gabor Miklos2

  • 1 Medical Oncology and Palliative Care, Cabrini Health, Melbourne, VIC.
  • 2 Secure Genetics, Sydney, NSW.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.